113 related articles for article (PubMed ID: 20138735)
1. Implication of the CD47 pathway in autoimmune diabetes.
Dugas V; Beauchamp C; Chabot-Roy G; Hillhouse EE; Lesage S
J Autoimmun; 2010 Aug; 35(1):23-32. PubMed ID: 20138735
[TBL] [Abstract][Full Text] [Related]
2. Targeting SIRP-α protects from type 2-driven allergic airway inflammation.
Raymond M; Van VQ; Rubio M; Welzenbach K; Sarfati M
Eur J Immunol; 2010 Dec; 40(12):3510-8. PubMed ID: 21108471
[TBL] [Abstract][Full Text] [Related]
3. Abrogation of ICOS/ICOS ligand costimulation in NOD mice results in autoimmune deviation toward the neuromuscular system.
Prevot N; Briet C; Lassmann H; Tardivel I; Roy E; Morin J; Mak TW; Tafuri A; Boitard C
Eur J Immunol; 2010 Aug; 40(8):2267-76. PubMed ID: 20544729
[TBL] [Abstract][Full Text] [Related]
4. Thymus and autoimmunity: production of CD25+CD4+ naturally anergic and suppressive T cells as a key function of the thymus in maintaining immunologic self-tolerance.
Itoh M; Takahashi T; Sakaguchi N; Kuniyasu Y; Shimizu J; Otsuka F; Sakaguchi S
J Immunol; 1999 May; 162(9):5317-26. PubMed ID: 10228007
[TBL] [Abstract][Full Text] [Related]
5. Pancreatic infiltration but not diabetes occurs in the relative absence of MHC class II-restricted CD4 T cells: studies using NOD/CIITA-deficient mice.
Mora C; Wong FS; Chang CH; Flavell RA
J Immunol; 1999 Apr; 162(8):4576-88. PubMed ID: 10201997
[TBL] [Abstract][Full Text] [Related]
6. Analysis of the roles of CD4+ and CD8+ T cells in autoimmune diabetes of NOD mice using transfer to NOD athymic nude mice.
Yagi H; Matsumoto M; Kunimoto K; Kawaguchi J; Makino S; Harada M
Eur J Immunol; 1992 Sep; 22(9):2387-93. PubMed ID: 1516628
[TBL] [Abstract][Full Text] [Related]
7. Mature mainstream TCR alpha beta+CD4+ thymocytes expressing L-selectin mediate "active tolerance" in the nonobese diabetic mouse.
Herbelin A; Gombert JM; Lepault F; Bach JF; Chatenoud L
J Immunol; 1998 Sep; 161(5):2620-8. PubMed ID: 9725264
[TBL] [Abstract][Full Text] [Related]
8. Absence of CD47 in vivo influences thymic dendritic cell subset proportions but not negative selection of thymocytes.
Guimont-Desrochers F; Beauchamp C; Chabot-Roy G; Dugas V; Hillhouse EE; Dusseault J; Langlois G; Gautier-Ethier P; Darwiche J; Sarfati M; Lesage S
Int Immunol; 2009 Feb; 21(2):167-77. PubMed ID: 19147837
[TBL] [Abstract][Full Text] [Related]
9. Transfer of autoimmune diabetes from diabetic NOD mice to NOD athymic nude mice: the roles of T cell subsets in the pathogenesis.
Matsumoto M; Yagi H; Kunimoto K; Kawaguchi J; Makino S; Harada M
Cell Immunol; 1993 Apr; 148(1):189-97. PubMed ID: 8098666
[TBL] [Abstract][Full Text] [Related]
10. Unique role of CD4+CD62L+ regulatory T cells in the control of autoimmune diabetes in T cell receptor transgenic mice.
You S; Slehoffer G; Barriot S; Bach JF; Chatenoud L
Proc Natl Acad Sci U S A; 2004 Oct; 101 Suppl 2(Suppl 2):14580-5. PubMed ID: 15340148
[TBL] [Abstract][Full Text] [Related]
11. Functional waning of naturally occurring CD4+ regulatory T-cells contributes to the onset of autoimmune diabetes.
Tritt M; Sgouroudis E; d'Hennezel E; Albanese A; Piccirillo CA
Diabetes; 2008 Jan; 57(1):113-23. PubMed ID: 17928397
[TBL] [Abstract][Full Text] [Related]
12. A defect in central tolerance in NOD mice.
Kishimoto H; Sprent J
Nat Immunol; 2001 Nov; 2(11):1025-31. PubMed ID: 11668341
[TBL] [Abstract][Full Text] [Related]
13. Graded attenuation of TCR signaling elicits distinct autoimmune diseases by altering thymic T cell selection and regulatory T cell function.
Tanaka S; Maeda S; Hashimoto M; Fujimori C; Ito Y; Teradaira S; Hirota K; Yoshitomi H; Katakai T; Shimizu A; Nomura T; Sakaguchi N; Sakaguchi S
J Immunol; 2010 Aug; 185(4):2295-305. PubMed ID: 20644168
[TBL] [Abstract][Full Text] [Related]
14. I-Ag7-mediated antigen presentation by B lymphocytes is critical in overcoming a checkpoint in T cell tolerance to islet beta cells of nonobese diabetic mice.
Noorchashm H; Lieu YK; Noorchashm N; Rostami SY; Greeley SA; Schlachterman A; Song HK; Noto LE; Jevnikar AM; Barker CF; Naji A
J Immunol; 1999 Jul; 163(2):743-50. PubMed ID: 10395666
[TBL] [Abstract][Full Text] [Related]
15. CD3 antibody treatment stimulates the functional capability of regulatory T cells.
Chatenoud L
Novartis Found Symp; 2003; 252():279-86; discussion 286-90. PubMed ID: 14609225
[TBL] [Abstract][Full Text] [Related]
16. Effects and regulation of autoreactive CD8+ T cells in a transgenic mouse model of autoimmune hepatitis.
Zierden M; Kühnen E; Odenthal M; Dienes HP
Gastroenterology; 2010 Sep; 139(3):975-86, 986.e1-3. PubMed ID: 20639127
[TBL] [Abstract][Full Text] [Related]
17. Control of type 1 autoimmune diabetes by naturally occurring CD4+CD25+ regulatory T lymphocytes in neonatal NOD mice.
Piccirillo CA; Tritt M; Sgouroudis E; Albanese A; Pyzik M; Hay V
Ann N Y Acad Sci; 2005 Jun; 1051():72-87. PubMed ID: 16126946
[TBL] [Abstract][Full Text] [Related]
18. CD4+CD25+ regulatory T cells control the progression from periinsulitis to destructive insulitis in murine autoimmune diabetes.
Ott PA; Anderson MR; Tary-Lehmann M; Lehmann PV
Cell Immunol; 2005 May; 235(1):1-11. PubMed ID: 16122720
[TBL] [Abstract][Full Text] [Related]
19. Regulation of apoptosis in mature alphabeta+CD4-CD8- antigen-specific suppressor T cell clones.
Khan Q; Penninger JM; Yang L; Marra LE; Kozieradzki I; Zhang L
J Immunol; 1999 May; 162(10):5860-7. PubMed ID: 10229821
[TBL] [Abstract][Full Text] [Related]
20. Comparing the relative role of perforin/granzyme versus Fas/Fas ligand cytotoxic pathways in CD8+ T cell-mediated insulin-dependent diabetes mellitus.
Kreuwel HT; Morgan DJ; Krahl T; Ko A; Sarvetnick N; Sherman LA
J Immunol; 1999 Oct; 163(8):4335-41. PubMed ID: 10510373
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]